MENU

Aileron Therapeutics (ALRN) Ownership - Who owns Aileron Therapeutics?

Profile

Industry
Pharmaceuticals Major
Address
285 Summer Street
Phone
+1 617 995-0900
Employees
6
Web
https://www.aileronrx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
59.87M
P/E Ratio
N/A
Total Cash
6.99M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.83
Dividend Yield
N/A
Total Cash/Share
0.32
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ALRN
Capitalization
59.9M
P/E Ratio
N/A
Risk (Beta)
1.83
Dividend Yield
N/A
Total Cash
6.99M
Total Cash/Share
0.32
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
44.8M
P/B Ratio
1.34
Cash Flow
N/A
Earnings
-3.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
103K
Current Ratio
2.82
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-18.43M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-31.05
Shares Held By Institutions
10.9M
Shares Outstanding - Current
21.6M
Total Liabilities
7.86M
Total Volume MTD
N/A
Value
1
Gain YTD
-9.139
View a ticker or compare two or three
ALRN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of stapled peptide drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
285 Summer Street
Phone
+1 617 995-0900
Employees
6
Web
https://www.aileronrx.com